Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 06, 2015 3:29 PM ET

Biotechnology

Company Overview of EDP Biotech Corporation

Company Overview

EDP Biotech Corporation, a medical device company, engages in the development and sale of immunodiagnostic tests for humans and animals. It identifies and purifies proteins in the early stages of biological changes for the production of in vitro diagnostic tests. The company’s ColoMarker test is a tool for early detection of Colon Cancer through a sample of blood. The company was founded in 2005 and is based in Knoxville, Tennessee.

6701 Baum Drive

Suite 110

Knoxville, TN 37919

United States

Founded in 2005

Phone:

865-246-0514

Fax:

865-971-1969

Key Executives for EDP Biotech Corporation

Chief Executive Officer and Director
Age: 51
Founder and Chairman
Age: 74
Chief Administrative Officer
Age: 55
Vice President of Business Development
Vice President of Research and Development
Compensation as of Fiscal Year 2014.

EDP Biotech Corporation Key Developments

EDP Biotech Corporation Announces CE Mark Approval for ColoMarker an in Vitro Diagnostic Aid in Early Detection of Colon Cancer and Plans for Commercialization in Europe

EDP Biotech Corporation has announced CE Mark approval for ColoMarker, an aid in early detection of Colon Cancer. This is a critical step toward commercialization of this unique product which will initially be introduced in the thirty member states belonging to the European Economic Area (EEA). The EDP ColoMarker test is a quick and easy tool for clinicians as an aid in early detection of colon cancer when it is most treatable, and only requires a small sample of blood. EDP expects that ColoMarker's affordable cost (priced somewhere between IFOBT and FIT stool tests), effectiveness, and the convenience of a whole blood test will significantly improve compliance compared to colonoscopy-based cancer screenings and existing fecal testing options.

EDP Biotech Corporation Announces Board Appointments

EDP Biotech Corporation announced that Dr. William (Bill) H. West and former Chairman, President and CEO of Regions Financial Corporation, Jackson (Jack) W. Moore will be joining the company’s esteemed board of directors. Dr. William (Bill) H. West is the Founder-Emeritus of the West Clinic in Memphis, Tenn. Dr. West is board certified in internal medicine and medical oncology, and has a career long interest in healthcare delivery systems. Jackson (Jack) W. Moore is a Director of Methodist LeBonheur Healthcare., and is also the retired Executive Chairman, President and CEO of Regions Financial Corporation. Mr. Moore currently serves as the Vice Chairman of the Board of Trustees at Vanderbilt University.

EDP Biotech Plans to Commercialize ColoMarker

EDP Biotech announced its plans to commercialize the product and bring the new technology to market. Unlike other diagnostic tests currently in development, the ColoMarker test detects a level of CA11-19 antigen, a specific protein molecule found in the bloodstream. While every human being produces this protein, elevated levels in the bloodstream suggest the presence of colon cancer. ColoMarker(TM) has proven to be effective in identifying elevated levels of a biomarker in the bloodstream in 95% of early stage colorectal cancers, when the disease is most treatable and survival rates are highest. To date, physicians have relied primarily on colonoscopies and fecal occult blood testing (FOBT) to identify potential cases of early stage colon cancer.

Similar Private Companies By Industry

Company Name Region
Mariposa Biotechnology, Inc. United States
Stella Blu, Inc. United States
APE-BridgePath Scientific, LLC United States
Genomic Expression Inc. United States
Clinical Data, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EDP Biotech Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.